Cargando…

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms

Parkinson’s Disease (PD) is a disease that involves neurodegeneration and is characterised by the motor symptoms which include muscle rigidity, tremor, and bradykinesia. Other non-motor symptoms include pain, depression, anxiety, and psychosis. This disease affects up to ten million people worldwide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivanandy, Palanisamy, Leey, Tan Choo, Xiang, Tan Chi, Ling, Tan Chi, Wey Han, Sean Ang, Semilan, Samantha Lia Anak, Hong, Phoon Kok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744877/ https://www.ncbi.nlm.nih.gov/pubmed/35010624 http://dx.doi.org/10.3390/ijerph19010364

Ejemplares similares

Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
por: Di Luca, Daniel Garbin, et al.
Publicado: (2022)

Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition
por: Taddei, Raquel N., et al.
Publicado: (2017)

Efficacy and Safety of Two-Drug Regimens That Are Approved from 2018 to 2022 for the Treatment of Human Immunodeficiency Virus (HIV) Disease and Its Opportunistic Infections
por: Sivanandy, Palanisamy, et al.
Publicado: (2023)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Evaluation of patient safety culture among Malaysian retail pharmacists: results of a self-reported survey
por: Sivanandy, Palanisamy, et al.
Publicado: (2016)

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016)

Drug Utilisation Review among Geriatric Patients with Noncommunicable Diseases in a Primary Care Setting in Malaysia
por: Manirajan, Priya, et al.
Publicado: (2023)

Nonmotor Symptoms in a Malaysian Parkinson's Disease Population
por: Azmin, Shahrul, et al.
Publicado: (2014)

Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson’s Disease
por: Yu, Rwei-Ling, et al.
Publicado: (2021)

Parkinson’s disease or Parkinson symptoms following seasonal influenza
por: Toovey, Stephen, et al.
Publicado: (2011)

Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm
por: Yong, Ming-Hui, et al.
Publicado: (2013)

Recent Developments in Parkinson's Disease
por: Tsai, Diane C.
Publicado: (1986)

Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease
por: Zhang, Yu, et al.
Publicado: (2018)

Advancement on Sustained Antiviral Ocular Drug Delivery for Herpes Simplex Virus Keratitis: Recent Update on Potential Investigation
por: Pandey, Manisha, et al.
Publicado: (2020)

Parkinson’s severity classification from wearable devices
por: Tan, Yayan
Publicado: (2021)

Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
por: Baldelli, Luca, et al.
Publicado: (2021)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Parkinson's Disease Caregiver Strain in Singapore
por: Tan, Siok-Bee, et al.
Publicado: (2020)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research
por: Pandey, Manisha, et al.
Publicado: (2021)

SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease
por: Yong, Alisa CW, et al.
Publicado: (2020)

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
por: Palanisamy, Sivanandy, et al.
Publicado: (2018)

Visual Symptoms in Parkinson's Disease
por: Armstrong, R. A.
Publicado: (2011)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Nonmotor Symptoms of Parkinson's Disease
por: Wu, Shey-Lin, et al.
Publicado: (2017)

Are the Symptoms of Parkinsonism Cortical in Origin?()()
por: Arbuthnott, Gordon W., et al.
Publicado: (2016)

Social Symptoms of Parkinson's Disease
por: Prenger, Margaret T. M., et al.
Publicado: (2020)

Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease
por: Lee, Hye Mi, et al.
Publicado: (2015)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
por: Skogar, Orjan, et al.
Publicado: (2018)

Recent developments in biomarkers in Parkinson disease
por: Schapira, Anthony H.V.
Publicado: (2013)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Recent advances in treating Parkinson’s disease
por: Oertel, Wolfgang H.
Publicado: (2017)

Recent developments in the treatment of Parkinson's Disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Purposeless Groaning in Parkinson’s Disease
por: Lim, Shen-Yang, et al.
Publicado: (2018)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

Role of Physical Activity in Parkinson's Disease
por: Bhalsing, Ketaki S., et al.
Publicado: (2018)

A feasibility pilot study of the effects of neurostimulation on swallowing function in Parkinson’s Disease [version 2; peer review: 1 approved, 3 approved with reservations, 1 not approved]
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t99a6nfq3qrt103ernaq43itv1